GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Asensus Surgical Inc (FRA:2TX) » Definitions » EV-to-Revenue

Asensus Surgical (FRA:2TX) EV-to-Revenue : 7.51 (As of May. 21, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Asensus Surgical EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Asensus Surgical's enterprise value is €60.29 Mil. Asensus Surgical's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €8.03 Mil. Therefore, Asensus Surgical's EV-to-Revenue for today is 7.51.

The historical rank and industry rank for Asensus Surgical's EV-to-Revenue or its related term are showing as below:

FRA:2TX' s EV-to-Revenue Range Over the Past 10 Years
Min: -1.62   Med: 29.57   Max: 3232.43
Current: 7.51

During the past 13 years, the highest EV-to-Revenue of Asensus Surgical was 3232.43. The lowest was -1.62. And the median was 29.57.

FRA:2TX's EV-to-Revenue is ranked worse than
75.78% of 830 companies
in the Medical Devices & Instruments industry
Industry Median: 3.265 vs FRA:2TX: 7.51

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-21), Asensus Surgical's stock price is €0.234. Asensus Surgical's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.03. Therefore, Asensus Surgical's PS Ratio for today is 7.55.


Asensus Surgical EV-to-Revenue Historical Data

The historical data trend for Asensus Surgical's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asensus Surgical EV-to-Revenue Chart

Asensus Surgical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.57 19.03 20.46 2.43 8.06

Asensus Surgical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.21 12.24 7.79 8.06 6.88

Competitive Comparison of Asensus Surgical's EV-to-Revenue

For the Medical Devices subindustry, Asensus Surgical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asensus Surgical's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Asensus Surgical's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Asensus Surgical's EV-to-Revenue falls into.



Asensus Surgical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Asensus Surgical's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=60.287/8.031
=7.51

Asensus Surgical's current Enterprise Value is €60.29 Mil.
Asensus Surgical's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €8.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asensus Surgical  (FRA:2TX) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Asensus Surgical's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.234/0.031
=7.55

Asensus Surgical's share price for today is €0.234.
Asensus Surgical's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asensus Surgical EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Asensus Surgical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Asensus Surgical (FRA:2TX) Business Description

Traded in Other Exchanges
Address
1 TW Alexander Drive, Suite 160, Durham, NC, USA, 27703
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.

Asensus Surgical (FRA:2TX) Headlines

No Headlines